Biopharma firm Radius Health is going private in an $890M M&A deal
Two private equity firms have reached an $890 million deal to buy Radius Health, a company whose main asset is the commercialized osteoporosis drug Tymlos. […]
Two private equity firms have reached an $890 million deal to buy Radius Health, a company whose main asset is the commercialized osteoporosis drug Tymlos. […]
NICE has reversed its stance on UCB and Amgen’s severe osteoporosis therapy Evenity, saying out can be prescribed on the NHS for women with the […]
New Delhi, India, More than 50 per cent of the world’s hip fractures are expected to occur in the Asia Pacific by the year 2050. […]
An artificial intelligence-based tool for identifying hard-to-detect spinal fractures, developed by Belgian drugmaker UCB, has been licensed out to ImageBiopsy Lab for further development. The […]
Read about news from life science companies Emulate, Astrocyte Pharmaceuticals and Bone Health Technologies.
Do You Know Your Risk of Fragility Fractures? A fragility fracture may be the first obvious sign of osteoporosis. It should trigger an evaluation of […]
Shots: Cadila has launched NuPTH an osteoporosis biosimilar of Forteo in India. The NuPTH is used for the treatment of osteoporosis and in patients with […]
Date: July 13, 2020 Issue #: 1602 Summary: View the Comparison Table: Some Drugs for Postmenopausal Osteoporosis
Date: July 13, 2020 Issue #: 1602 Summary: US guidelines recommend pharmacologic therapy for postmenopausal women with a bone density T-score (standard deviation from normal […]
Copyright © 2024 | WordPress Theme by MH Themes